Investors are underpricing Alliance Pharma's growth potential
Pharmaceutical specialist Alliance Pharma (APH:AIM) runs an asset-light business model, making it unique in the sector and very cash generative.Alliance Pharma owns or licenses over 90 pharmaceutical and healthcare products and...
03 October 2019